Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamazym in alpha-mannosidosis
NCT01285700Phase 2Unknown
- Sponsor
- Zymenex
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Countries
- 1
01
Overview
A Phase 2 trial of velmanase alfa in alpha-mannosidosis, sponsored by Zymenex. Status: unknown.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on NCT01285700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285700.